BOSTON--(BUSINESS WIRE)--OM1, a leading real-world data, outcomes, and technology company with a focus on chronic conditions, today announced the launch of two new Real-World Analytics products – ...

BOSTON--(BUSINESS WIRE)--OM1, a leading real-world data and technology company with a focus on chronic conditions, today announced the launch of OM1 Aspen, its novel, automated study platform for ...

OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior ...

OM1, the leader in real-world data and AI-driven insights in mental health for life sciences, announced an upcoming poster presentation hosted by Jessica Probst, OM1’s Principal, Real World Evidence.

BOSTON, August 12, 2025--(BUSINESS WIRE)--OM1, a leader in real-world evidence (RWE) generation and AI-driven insights for healthcare and life sciences, today announced the expansion of its Neurology ...

OM1, a company that provides chronic disease registries and real-world data, banked $85 million backed by Kaiser Permanente and General Catalyst. The Boston-based health technology company says it ...

BOSTON, April 20, 2021 /PRNewswire/ -- OM1, a leading real-world data, outcomes and technology company with a focus on chronic diseases, announced its Rheumatoid Arthritis (RA) registry now includes ...

BOSTON, Feb. 18, 2021 /PRNewswire/ -- OM1, a leading real-world data (RWD), health outcomes and technology company, today announced the publication of clinical trial results in JAMA Network Open ...

Harvard trained surgeon and big data entrepreneur Dr. Richard Gliklich has been working to improve the management of chronic conditions by organising, analysing and applying health outcomes data since ...